drugset / Trial / NCT03335163

The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users

NCT03335163

NaSingle-groupOpen-labelTreatment

Summary

A prospective, non-inferiority study to evaluate the pharmacokinetic effect of topiramate on serum Etonogestrel (ENG) levels in contraceptive implant users.

Timeline

Start
2018-03-15
Primary completion
2021-04-22
Completion
2021-04-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 200 mg Oral

Indications